BackgroundDry needling (DN) and percutaneous electrical nerve stimulation (PENS) are widely
used techniques in the treatment of myofascial pain.ObjectiveTo investigate the immediate and short-term effects of the combination of DN and
PENS compared to DN alone on the upper trapezius muscle.MethodThis is a 72-hour follow-up single-blinded randomized controlled trial. Sixty-two
volunteer patients with chronic myofascial neck pain with active Myofascial
Trigger Points (MTrPs) in the upper trapezius muscle were recruited. Randomization
was performed, and 31 patients received DN treatment (DN group) and 31 received DN
and PENS (DN+PENS group). The primary outcomes were neck disability index (NDI)
and visual analog scale for pain for both post-needling soreness (PNS) and neck
pain intensity (NPI). Pressure pain threshold (PPT) and cervical range of motion
(CROM) were the secondary outcomes. ResultsWe detected between-group differences in NPI and PNS in favor of the DN+PENS group
immediately after treatment. No between-group differences in NDI were
observed.ConclusionPENS application after dry needling treatment is more effective than dry needling
alone for decreasing soreness in the short term and improving neck pain intensity
immediately in patients with myofascial chronic neck pain.
DDN in the upper trapezius MTrP improved pain at a 1-wk follow-up, but improvements were not significantly different among DDN dosages. A higher number of patients with neck pain improvements superior to the moderate clinically important differences were observed when eliciting 6 LTRs and LTRs until exhaustion compared with not eliciting LTRs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.